| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13591* | 2021 |
| The DNA-damage response in human biology and disease SP Jackson, J Bartek Nature 461 (7267), 1071-1078, 2009 | 7001 | 2009 |
| Cell-cycle checkpoints and cancer MB Kastan, J Bartek Nature 432 (7015), 316-323, 2004 | 3745 | 2004 |
| DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis J Bartkova, Z Hořejší, K Koed, A Krämer, F Tort, K Zieger, P Guldberg, ... Nature 434 (7035), 864-870, 2005 | 3249 | 2005 |
| The causes and consequences of genetic heterogeneity in cancer evolution RA Burrell, N McGranahan, J Bartek, C Swanton Nature 501 (7467), 338-345, 2013 | 2628 | 2013 |
| Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints J Bartkova, N Rezaei, M Liontos, P Karakaidos, D Kletsas, N Issaeva, ... Nature 444 (7119), 633-637, 2006 | 2328 | 2006 |
| An oncogene-induced DNA damage model for cancer development TD Halazonetis, VG Gorgoulis, J Bartek science 319 (5868), 1352-1355, 2008 | 2159 | 2008 |
| Chk1 and Chk2 kinases in checkpoint control and cancer J Bartek, J Lukas Cancer cell 3 (5), 421-429, 2003 | 2001 | 2003 |
| Human CtIP promotes DNA end resection AA Sartori, C Lukas, J Coates, M Mistrik, S Fu, J Bartek, R Baer, J Lukas, ... Nature 450 (7169), 509-514, 2007 | 1739 | 2007 |
| The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis J Falck, N Mailand, RG Syljuåsen, J Bartek, J Lukas Nature 410 (6830), 842-847, 2001 | 1530 | 2001 |
| ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks A Jazayeri, J Falck, C Lukas, J Bartek, GCM Smith, J Lukas, SP Jackson Nature cell biology 8 (1), 37-45, 2006 | 1381 | 2006 |
| RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins N Mailand, S Bekker-Jensen, H Faustrup, F Melander, J Bartek, C Lukas, ... Cell 131 (5), 887-900, 2007 | 1375 | 2007 |
| Increased expression of mutant forms of p53 oncogene in primary lung cancer R Iggo, J Bartek, D Lane, K Gatter, AL Harris The Lancet 335 (8691), 675-679, 1990 | 1362 | 1990 |
| Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 J Lukas, D Parry, L Aagaard, DJ Mann, J Bartkova, M Strauss, G Peters, ... Nature 375 (6531), 503-506, 1995 | 1220 | 1995 |
| 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers P Bouwman, A Aly, JM Escandell, M Pieterse, J Bartkova, ... Nature structural & molecular biology 17 (6), 688-695, 2010 | 1099 | 2010 |
| RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins C Doil, N Mailand, S Bekker-Jensen, P Menard, DH Larsen, R Pepperkok, ... Cell 136 (3), 435-446, 2009 | 1098 | 2009 |
| Rapid destruction of human Cdc25A in response to DNA damage N Mailand, J Falck, C Lukas, RG Syljuåsen, M Welcker, J Bartek, J Lukas Science 288 (5470), 1425-1429, 2000 | 1084 | 2000 |
| Checking on DNA damage in S phase J Bartek, C Lukas, J Lukas Nature reviews Molecular cell biology 5 (10), 792-804, 2004 | 1083 | 2004 |
| DNA damage checkpoints: from initiation to recovery or adaptation J Bartek, J Lukas Current opinion in cell biology 19 (2), 238-245, 2007 | 1014 | 2007 |
| Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining C Gillett, V Fantl, R Smith, C Fisher, J Bartek, C Dickson, D Barnes, ... Cancer research 54 (7), 1812-1817, 1994 | 958 | 1994 |
